1 in 4 Antibiotic Prescriptions Wasted on Unresponsive Patient Conditions, Including COVID-19
A five-year trend study shows a rebound in inappropriate use of antibiotics after an early pandemic dip.
Category: US Pharmaceuticals
US Pharmaceuticals
Latest
US Pharmaceuticals
Latest
FDA Approves Nonsteroidal Treatment for Duchenne Muscular Dystrophy
Duvyzat is the first nonsteroidal drug approved to treat patients with all genetic variants of Duchenne Muscular Dystrophy.
US Pharmaceuticals
Latest
Pfizer’s RSV Vaccine Protective Through Two Seasons in Older Adults
New top-line results show the bivalent vaccine maintained consistently high protective efficacy for both RSV A and RSV B disease through two seasons after a single dose.
Singulair Black Box Warning Did Little to Alert Patients to Potential Side Effects
An article published by the New York Times outlines how an FDA black box warning for the asthma drug Singulair (montelukast) did little to alert patients to its potential mental health side effects or to dissuade physicians from prescribing it.
Read More
Congress to Investigate High Cost of Asthma Inhalers
A Congressional committee led by Senator Bernie Sanders are demanding answers from pharmaceutical companies on the high costs of asthma inhalers, according to a report by The Hill.
Read More
Yupelri Not Superior to Spiriva in Phase 4 Trial
Theravance Biopharma’s COPD treatment Yupelri was not superior to Boehringer Ingelheim’s Spiriva Handihaler, according to results from a phase 4 study reported by Theravance.
Read More
Preexisting Conditions May Elevate Heart Disorder Risk Post COVID-19 Vaccine
Cedars-Sinai investigators suggest it may be helpful to keep an eye on patients with underlying health issues after COVID-19 vaccination to monitor for post-vaccine POTS, a condition that causes an abnormal increase in heart rate after standing or sitting up.
Read More
Full RSV Vaccination Could Cut Senior Hospitalizations by 91.7%
Respiratory syncytial virus vaccines recently approved for people 60 and older would dramatically reduce the disease’s burden of illness and death if they were widely adopted like annual influenza vaccines, a Yale University study finds.
Read More
FDA Clears INOmax Evolve DS
The INOmax Evolve DS is Mallinckrodt’s next-generation nitric oxide delivery system that includes a primary delivery system, a monitoring system, an electronic blender, automated backup delivery, mini-cylinders, and more.
Read More
FDA Grants Priority Review to Merck’s Pneumococcal Conjugate Vaccine for Adults
The FDA accepted for priority review a new Biologics License Application for V116, Merck’s investigational 21-valent pneumococcal conjugate vaccine designed to help prevent invasive pneumococcal disease and pneumococcal pneumonia in adults.
Read More
Five Pharma Approvals from 2023
In some of the most notable pharmaceutical approvals from 2023, drugs for RSV, CF, COVID-19, sickle cell disease, and opioid overdose received an FDA stamp in 2023.
Read More
Benralizumab Reduces Need for Inhaled Steroids for Severe Asthma
Findings from a multinational study demonstrated that 92% of patients using benralizumab could safely reduce inhaled steroid dose, and more than 60% could stop all use.
Read More
Multimillion Dollar Price Tags for Sickle Cell Gene Therapies
Two gene therapies approved by the FDA last week for the treatment of sickle cell disease will have multimillion dollar price tags for patients (and insurers), according to Reuters.
Read More
Dupilumab May Help Treat Lung Cancer, Reduce Tumors
Combining immunotherapy with dupilumab boosted lung cancer patients’ immune systems, with one out of the six experiencing significant tumor reduction, according to findings published in Nature.
Read More
Could Dupilumab Help Treat Lung Cancer?
In an early parallel study in humans with non-small cell lung cancer, combining immunotherapy with dupilumab boosted patients’ immune systems, with one out of the six experiencing significant tumor reduction.
Read More